A lack of testing is keeping public health officials in the dark about how widespread monkeypox is in the United States and posing new uncertainties for the medical system.
Why it matters: The lack of robust disease-tracking harks back to the troubled early response to COVID-19 and could bode ill for local health systems still grappling with the virus, its aftereffects and the impending flu season.
